Paolo Ciana, received his laurea degree with honor in Biological Sciences in 1988 at the University of Pavia, the Ph.D. in Experimental Hematology in 1995 at the University of Milano and the Specialization in Applied Genetics in 1997 at the University of Pavia. He is currently Associate Professor at the Department of Pharmacological Sciences at the University of Milan. He has more than two decades experience in the study of nuclear receptors in physiology and oncogenesis through a combined biochemical, pharmacological, molecular biology and in vivo imaging approach. In the last 15 years, he has developed a multi-technological research strategy based on in vivo imaging, transcriptomic and animal transgenesis with reporter genes, to study physiological and pathogenetic processes (mainly oncogenesis) in vivo; his current research in the mammary oncogenesis aims, through the application of these methodologies, at identifying the molecular events driving the breast cancer progression and to suggest innovative therapeutic strategies for the cure of this disease. Paolo Ciana is co-author of 115 publications (international publications in "peer reviewed" journals, contribution to book chapters and patents); H-index=35 (google scholar), 4651 citations. For his research in Biotechnology and Pharmacology he was awarded of the Biotechnological Research Prize of the University of Milano 2002, Galeno Prize 2003, Italian Society of Pharmacology and Farmindustria Award 2004, “Emilio Marmo” Prize of the Italian Society of Pharmacology for the best scientific contribution 2005 and of the international prize Eurotox/HSI/P&G Animal Welfare and Alternative Awards 2006. His research has been continuously supported by EU, Italian Telethon, Italian Association for Cancer Research and Italian Ministry of University and Research. He is co-founder of TOP s.r.l. a spin-off of the University of Milan.